Product name:Ozagrel Sodium
CAS: 130952-46-4
Molecular Formula: C13H11N2NaO2
Molecular Weight: 250.23
Product description:This product is a thrombus alkanes (TX) synthase inhibitor, can inhibit prostaglandin H2 (PGH2) alkanes generated thrombosis A2 (TXA2), platelet derived PGH2 to endothelial cells. Endothelial cells to synthesize PGI2, from but improve prostaglandin PGI2 and TXA2 balance anomalies. Theory can inhibit blood platelet aggregation and expansion tube. This product can improve the acute phase of cerebral thrombus dyskinesia, improve circulation and improve the acute phase of cerebral ischemia Cerebral ischemia, energy metabolic abnormalities. Animal studies have shown that intravenous drug can reduce plasma TXB2 levels, 6 - Keto - PGF1 alpha/TXB2 ratio decreased, the caused by different inducers are inhibition of platelet aggregation of rat middle cerebral artery occlusion caused by cerebral infarction have preventive action. This product for one half of the platelet aggregation inhibition concentration of IC50 is low, is 4 nm. With their own blood into web membrane.